On the evening of March 15th, the New Coronavirus (2019-nCoV) antigen detection kit developed by Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) was approved by the State Food and drug administration. This is the first covid-19 antigen self-test product approved for listing in Hubei ProvinceP align = “center” picture provided by respondents
On March 12, after the covid-19 antigen self-test products of the first five enterprises in China were approved and registered, Hubei Provincial Food and Drug Administration held a meeting of key enterprises and chambers of Commerce to start the emergency approval mechanism, coordinate medical institutions to accelerate clinical trials, complete the on-site verification task within 24 hours, and spare no effort to promote the approval and registration of covid-19 antigen products in the province as soon as possible.
It is reported that the covid-19 antigen detection kit developed by Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) is an important supplement to covid-19 nucleic acid detection because of its convenient operation, rapid results in 15 minutes, no sampling environment requirements and lower cost.
At present, the product has obtained EU CE certification in the early stage, with an export volume of more than 100 million people. After the Chinese registration is approved, the daily output will reach more than 6 million people / day.
